The Liver Meeting 2019-HCV+ Donors in Liver Transplantation

Video Transcription

Video Summary

The speaker discusses the use of HCV-positive donors in liver transplantation due to the shortage of organs. They highlight the shift towards using HCV-viremic donors in HCV-negative recipients due to fewer HCV-positive candidates on the waiting list. Studies show promising results with SVR rates close to 100% and similar graft survival compared to HCV-negative donors. Challenges include access to DAAs, potential risks of rejection, and uncertainties about optimal timing for treatment initiation post-transplant. The transcript also touches on concerns about the impact of rapid virus clearance on rejection rates. Overall, the use of HCV-positive donors in liver transplants shows potential benefits but requires careful consideration of various factors for successful outcomes.

Asset Caption

Presenter: Norah Terrault

Keywords

HCV-positive donors

liver transplantation

organ shortage

HCV-viremic donors

SVR rates

graft survival